Develops fluorescent dynorphin tracers for visualizing kappa opioid receptors, suggesting new insights into receptor location.
The kappa opioid receptor (KOR) controls a wide variety of biological processes, including pain and reward responses. However, its precise spatiotemporal location remains poorly understood due to limited selective molecular tools. We addressed this problem by developing dynorphin-based fluorescent KOR tracers that are selective for KOR over its closely related mu- and delta-family members (MOR, DOR). Our lead tracer is highly selective for KOR (>360-fold over MOR and DOR) and can effectively visualize KORs in the somatodendritic compartment of cultured primary cortical neurons, as well as in superficial layer neurons of the spinal cord dorsal horn. Furthermore, it blocked the KOR agonist U50,488-induced reduction in the excitatory drive of spinal cord neurons. The developed tracer can also be immobilized with paraformaldehyde and used for post hoc imaging, rendering it a highly valuable tool for mapping KOR expression in physiological and pathophysiological contexts.
No takes yet. Share an insight, caveat, or question.
Kalaba et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: